Physician profile
Brian E Cohen
NPI 1962472837
$1,047.50
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $138 · 2021: $103 · 2022: $223.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.44 | 2019-2022 | |
| Coopersurgical, INC. | $182.02 | 2019-2022 | |
| Allergan, INC. | $130.50 | 2019-2020 | |
| Amgen INC. | $117.96 | 2019-2020 | |
| Astellas Pharma US INC | $110.65 | 2019-2022 | |
| Pfizer INC. | $95.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $53.37 | 2019 | |
| Amag Pharmaceuticals, INC. | $40.72 | 2019 | |
| Lupin INC. | $27.54 | 2019 | |
| Alydia Health | $13.70 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.